AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04355312 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Use of Indocyanine Green in laparoscopic ovarian cystectomy
Description: During intraperitoneal cystectomy or Plasmajet destruction of the cyst, as a benign organic cyst requiring surgical treatment, peroperatively, at the end of the cystectomy procedure, injection by the anesthetist on a peripheral venous route of a bolus of Indocyanine green diluted 0.2mg / kg. Installation of the SPIES camera system (KARL STORZ GmbH \& Co.KG, Tuttlingen, Germany).~Evaluation of the degree of fluorescence at the location of cystectomy or destruction of the cyst.~A fluorescence score between 0 and 4 (on the model of a Likert scale) will be used for the evaluation of fluorescence.~A second reading of the Likert scale results will be carried out by a second inspector so that the score is as objective as possible. Then, second evaluation technique realized by the METAMORPH software, which will assign a raw and objective score according to the fluorescence visualized.
Study NCT02686697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-Carnosine
Study NCT02686697 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02686697 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Cognitive Training for 2 weeks
Study NCT02686697 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Cognitive Training
Description: Cognitive Training for 2 weeks
Study NCT04641364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant human albumin injection
Description: single dose or multiple doses of intravenous infusion
Study NCT04641364 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dose intravenous infusion of 0.9% sodium chloride injection
Study NCT04641364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: human albumin injection
Description: multiple doses of intravenous infusion
Study NCT03318159 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Posaconazole
Description: Dosing of posaconazole Posaconazole tablet 300 mg twice daily on day 1; Maintenance dose: 300 mg once daily on day 2 and thereafter. Treatment period: 4 weeks~\*if posaconazole tablet intolerance: posaconazole suspension 200mg tid
Study NCT03754283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Indirect bonding
Description: Indirect bonding is the technique where orthodontic appliances are first placed on a model of the patient and then transferred to the patient using some kinf of trays
Study NCT03754283 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Indirect bonding
Description: Indirect bonding is the technique where orthodontic appliances are first placed on a model of the patient and then transferred to the patient using some kinf of trays
Study NCT01425190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Boceprevir
Description: Single dose of boceprevir powder prior to breakfast in a dosing vehicle of chocolate pudding (i.e., a mousse or custard), apple sauce, Nutella, fruit pudding such as strawberry, cherry, or raspberry pudding, or yogurt or a similar semi-solid product into which the boceprevir powder can be evenly stirred
Study NCT00619411 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy for Depressed Adolescents & Parents
Description: 15 weekly psychotherapy sessions
Study NCT01786616 — intervention group
Intervention type: DRUG
Intervention: Formoterol
Study NCT01240122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biotrue MPS
Description: Multi-purpose contact lens care solution
Study NCT01240122 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational MPS
Description: Multi-purpose contact lens care solution
Study NCT02294721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard BLS
Description: Resuscitation without feedback devices, standard manual standard basic life support
Study NCT02294721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The CPREazy
Description: feedback device-1
Study NCT02294721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TrueCPR
Description: feedback device -2
Study NCT02202525 — intervention group
Intervention type: DRUG
Intervention: Micardis®
Study NCT02507726 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flexima Active soft convexe
Description: The Investigational Device will be used during 14 +- 3 days.
Study NCT02202525 — intervention group
Intervention type: DRUG
Intervention: Other hypertensives
Study NCT01045525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Phlebotomy
Description: From 300 to 400mL for women; From 350 to 450mL for men
Study NCT01045525 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle and diet advices
Description: 2 Booklets with Dietary and physical activity advices
Study NCT02398799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducational support
Description: The intervention was based on a conceptual model from Stuifbergen. The model has sprung from Pender's model of health promotion and Bandura's self-efficacy theory. Cognitive-behavioral strategies were chosen to assist dyads in recognizing and modifying factors that contribute to physical and emotional distress by changing thoughts and behaviors and assisting dyads in solving problems related to implementing strategies for self-care.~Shared care is a dyadic process based on the assumption that each participant affects and is affected by the other. Shared goals and a shared commitment provide the essential building blocks of the dyad relationship. The dyad structure presents an opportunity for healthcare professionals to integrate a collaborative patient-partner centered effort.
Study NCT00113373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lapatinib ditosylate
Description: Given orally
Study NCT00113373 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT02294721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The CPR PRO APP
Description: feedback device -3
Study NCT02294721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The CardioPump
Description: feedback device- 4
Study NCT00740779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Description: Silodosin 8 mg daily
Study NCT00740779 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT00740779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silodosin 4 mg
Description: Silodosin 4 mg daily
Study NCT03438552 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: This radiotherapy may be administered with the CyberKnife® or a linear accelerator allowing stereotactic radiotherapy.
Study NCT02014376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SD-101 dermal cream (3%)
Description: SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-3.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 3% and other excipients.
Study NCT02014376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SD-101 Dermal Cream (6%)
Description: SD-101 is a white, crystalline powder that is formulated within an odorless, soft, white cream base. SD-101-6.0 cream contains allantoin, a diureide glyoxylic acid, at a concentration of 6% and other excipients.
Study NCT02014376 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle (SD-101 0%)
Description: A white, crystalline powder that is formulated within an odorless, soft, white cream base. It contains no allantoin, only excipients.
Study NCT02919111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ga-68 labeled PSMA-11 PET
Description: Patients will be imaged using Ga-68 labeled PSMA-11 PET to determine if the presence of metastatic disease. Prostate Specific Membrane Antigen (PSMA) is a protein expressed on prostate cancer cells that can be imaged using small molecules that target this protocol.
Study NCT04384146 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Cyclical Hypofractionated Palliative Radiation (Quad Shot)
Description: 3.7 Gy twice daily x 2 days for a total dose of 14.8 Gy per cycle. The next cycle will occur after a 21-28 day break.
Study NCT04384146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 questionnaire
Description: at baseline, each cycle of Quad Shot, and at 3 weeks, 3 months and 6 months after last cycle of Quad Shot.
Study NCT01531335 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hypocaloric hyperproteic nutrition
Description: 15 kcal per kg of body weight and 1.7 grams of protein per kg.
Study NCT01531335 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: 25 kcal per kg of body weight
Study NCT04017312 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Frequency Chest Wall Oscillation
Description: High frequency chest wall oscillation (HFCWO) therapy (also known as high-frequency chest-wall compression or HFCWC) is commonly prescribed to provide routine airway clearance in patients with bronchiectasis as well as other patients with a need for regular airway clearance therapy. HFCWO generates high velocity expiratory airflow. This airflow is thought to mobilize secretions by the sheer force created, effecting changes in rheology and moving mucus in a cephalad direction during the oscillation. The Vest® Airway Clearance System, a commonly used device, generates HFCWO using an air pulse generator and an inflatable garment that delivers pressure pulses to the thorax. These pressure pulses within the garment create HFCWO.
Study NCT04017312 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oscillating Positive Expiratory Pressure (OPEP)
Description: Oscillating PEP is an airway clearance technique, where the person blows all the way out many times through a device. These types of oscillating PEP devices work in two ways. Firstly, they use resistance to make it more difficult during the breath out, like non-oscillating PEP devices. Oscillating PEP devices also create vibrations when breathing out. The vibrations move mucus from the surface of the airways. After blowing through the device several times, the person will huff and cough to clear the mucus from the lungs.
Study NCT04452916 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Buchinger fasting
Description: Caloric intake of \< 250 kcal/d for 5 days
Study NCT04452916 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Buchinger fasting
Description: Caloric intake of \< 250 kcal/d for 5 days
Study NCT00829868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg Capsules
Description: 1 x 10 mg
Study NCT00829868 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SONATA® 10 mg capsules
Description: 1 x 10 mg
Study NCT01446523 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Syrup, 30 ml BD for 3 months in Gr. NL
Study NCT01446523 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactulose
Description: Syrup 30 ml BD for 12 weeks
Study NCT03697447 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endermotherapy
Description: Endermotherapy massage (mechanic massage) of burn scar
Study NCT02978521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Description: Session 1: ventilatory pattern training Session 2,3: ventilatory pattern + respiratory training with incentive spirometer Session 4-6: Sessions 1-3 training continues + training with Positive expiratory pressure device (Threshold PEP) and breathing trainer Threshold IMT) Sessions 7-9: Continue respiratory training + resistance training with RECK MOTOmed2 ergometer at a 30% intensity until 60% is achieved Session 10-12: Continue with previous training + treadmill training
Study NCT03241888 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Megestrol Acetate
Description: At a dosage of 160 mg/day
Study NCT00843960 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: behavioral adaptation and symptom management
Description: behavioral adaptation and symptom management
Study NCT03241888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate
Description: At a dosage of 160 mg/day
Study NCT03241888 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Description: Active ingredient: levonorgestrel 52mg. It is a hormone-releasing T-shaped intrauterine system.
Study NCT03241888 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Description: Active ingredient: levonorgestrel 52mg. It is a hormone-releasing T-shaped intrauterine system.
Study NCT01140204 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent
Study NCT00314782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD4054 (Zibotentan)
Description: oral tablet
Study NCT00314782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: intravenous infusion
Study NCT00314782 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT01935648 — intervention group
Intervention type: DRUG
Intervention: Ropivacaine
Study NCT03358095 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tannenbaum Fr 10 stent or WallFlex stent
Description: A plastic or metallic endoprosthesis is placed to the biliary ducts.
Study NCT03457090 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Examination : a TCD and Trans-Thoracic Echocardiography
Description: Examination that involves the completion of a TCD and an TTE (Trans-Thoracic Echocardiography) :~* To reports clinical parameters at the time of the examination : ECG data: sinus rhythm, atrial or ventricular arrhythmia, state of consciousness, heart rate, O2 saturation~* To review of pharmacological parameters at the time of the examination : presence of sedation; presence, type and dose of catecholamines.~* To collect biological data from the day of the examination : Partial Pressure of O2, PaCO2 (partial pressure) and hematocrit~* To collect possible additional examinations : brain scan, EEG. These are non-invasive exams that do not require patient displacement. Only the samples taken by the medical team as part of the treatment will be analyzed.
Study NCT05338476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Administered orally.
Study NCT05338476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Description: Administered orally.
Study NCT02668042 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: liveness tissue skin
Description: liveness tissue skin safety and effectiveness for the treatment of difficult to heal wounds
Study NCT02263417 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of Gpi
Study NCT02263417 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of Gpi
Study NCT02263417 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of STN
Study NCT02263417 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Deep Brain Stimulation (DBS) of STN
Study NCT01140204 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Implantation of a bare metal stent
Description: Bare Metal Stent
Study NCT04597801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcon
Description: Fluorescein sodium is administered intravenously with a bolus injection of 5 mg per kg of bodyweight 20-40 minutes prior to the planned tumor resection.
Study NCT04856280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kinesiological taping
Description: In KT Group, 6 sessions of KT were applied, starting on the 14th day of the menstrual cycle and 2 times a week for 3 weeks until the cycle ended.
Study NCT04856280 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: In the AE group, walking and climbing stairs were given during the menstrual cycle, 3 days a week, 45 minutes.
Study NCT03137823 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: throat culture
Description: throat culture - from the tonsills and from the bucal surface
Study NCT03986892 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical Activity
Description: Physical Activity
Study NCT01809431 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Using a two-group, repeated measures experimental design, this proposed study will test a 14-week intensive intervention on the benefits of breastfeeding, understanding gestational diabetes and risk of progression to prediabetes and type 2 diabetes, nutrition and exercise education, coping skills training, and physical activity (Phase I) and 3 months of continued monthly contact (Phase II) to help overweight women diagnosed with gestational diabetes improve metabolic, clinical, weight, adiposity, health behaviors and self-efficacy.
Study NCT02212795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 183mg
Description: Zabofloxacin 183mg single dose
Study NCT00672035 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.
Study NCT00672035 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Biological: heat-labile enterotoxin of E. coli (LT)
Description: LT patch applied on either the deltoid or the lower back.
Study NCT03196778 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low Dose Radiotherapy
Description: Patients will receive 10 fractions of very low dose hemi-body radiation, delivered, twice per week, over five weeks
Study NCT00693147 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Thyroidectomy
Description: Late postoperative course of patients with mini Video Assisted Thyroidectomy (miVAT) versus classic Thyroidectomy (T)
Study NCT02526290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intranasal Lacrimal Neurostimulator (Oculeve)
Description: Neurostimulation device
Study NCT03185026 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interventional group : PEPSUI psychoeducational program
Description: The program includes 10 weekly, 2-hours sessions led by two trained animators (nurse, medical doctor/psychologist), each focusing on a specific theme or skill :~1. Education on suicidal behavior (clinic and epidemiology), and conceptualization of the phenomenon on a matrix~2. Education on the suicidal crisis, identification of important life areas and values for the patient, experimentation on the way to use the matrix as a decision-making tool.~3. and 4) Self-assessment of suicidal ideations, coping strategies based on suicide ideation intensity and emotional tension (acceptation, distress tolerance, personal aid kit, and emergency care)~5) Stress-diathesis model of suicidal behavior, innovating cognitive skills (defusion), and valued actions 6) Stress factors (psychiatric diseases and negative life events), resilience, and contact with present moment 7) Suicidal vulnerability, personal strengths 8) Social support, skills to create quality relationships
Study NCT03185026 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation group
Description: Participants will be included in a standardized relaxation program, consisting of 10 weekly sessions lasting 2 hours. There will be 2 therapists for each patients group. Abdominal and muscular relaxation skills will be experimented.
Study NCT03097640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CHAMP
Description: CHAMP team members visit patients in the ED and on inpatient floors. Along with the patient's input, the team develops an Individualized Care Plan outlining the patient's medical and social history and providing recommendations to other providers on specific aspects of their care. Care plans are reviewed with patients on an individual basis and reviewed periodically by the CHAMP providers. CHAMP-enrolled participants are scheduled for physician and social worker follow-up appointments at the CHAMP clinic; this time is used to provide intensive case management, medical care, and psychosocial support.
Study NCT03624075 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: application of kinesio taping
Description: application of kinesio taping in the rectus femoris muscle and in the medial and lateral region of the knee
Study NCT03624075 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: application of kinesio taping
Description: application of kinesio taping in the rectus femoris muscle and in the medial and lateral region of the knee
Study NCT02212795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin 250mg
Description: Levofloxacin 250mg single dose
Study NCT02212795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zabofloxacin 367mg
Description: Zabofloxacin 367mg single dose
Study NCT01163331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Singing Therapy
Description: Singing therapy as a way to improve voice quality
Study NCT04223973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtrum A7+ insulin Pump
Description: Use of the Medtrum pump during 3 months in combination with a CGM (Continuous Glucose Measurement)